Bokus

and Translation Forum on Drug Discovery, Development

Visar alla böcker från författaren and Translation Forum on Drug Discovery, Development. Handla med fri frakt och snabb leverans.

  1. Accelerating the Development of Biomarkers for Drug Safety

    Accelerating the Development of Biomarkers for Drug Safety

    2009

  2. Public Health Emergency Medical Countermeasures Enterprise

    Public Health Emergency Medical Countermeasures Enterprise

    2010

  3. Addressing the Barriers to Pediatric Drug Development

    Addressing the Barriers to Pediatric Drug Development

    2008

  4. Emerging Safety Science

    Emerging Safety Science

    2008

  5. Understanding the Benefits and Risks of Pharmaceuticals

    Understanding the Benefits and Risks of Pharmaceuticals

    2007

  6. Breakthrough Business Models

    Breakthrough Business Models

    2009

  7. Challenges for the FDA

    Challenges for the FDA

    2007

  8. Transforming Clinical Research in the United States

    Transforming Clinical Research in the United States

    2010

  9. Building a National Framework for the Establishment of Regulatory Science for Drug Development

    Building a National Framework for the Establishment of Regulatory Science for Drug Development

    2011

  10. Direct-to-Consumer Genetic Testing

    Direct-to-Consumer Genetic Testing

    2010

  11. Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa

    Emerging Threat of Drug-Resistant Tuberculosis in Southern Africa

    2011

  12. New Profile of Drug-Resistant Tuberculosis in Russia

    New Profile of Drug-Resistant Tuberculosis in Russia

    2011

  13. Advancing Regulatory Science for Medical Countermeasure Development

    Advancing Regulatory Science for Medical Countermeasure Development

    2011

  14. Innovation in Drug Research and Development for Prevalent Chronic Diseases

    Innovation in Drug Research and Development for Prevalent Chronic Diseases

    2021

  15. Adverse Drug Event Reporting

    Adverse Drug Event Reporting

    2007

  16. Breakthrough Business Models

    Breakthrough Business Models

    2009

  17. Advancing Regulatory Science for Medical Countermeasure Development

    Advancing Regulatory Science for Medical Countermeasure Development

    2011

  18. Public Engagement and Clinical Trials

    Public Engagement and Clinical Trials

    2012

  19. Facing the Reality of Drug-Resistant Tuberculosis in India

    Facing the Reality of Drug-Resistant Tuberculosis in India

    2012

  20. Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development

    Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development

    2012

  21. Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development

    Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development

    2012

  22. Envisioning a Transformed Clinical Trials Enterprise in the United States

    Envisioning a Transformed Clinical Trials Enterprise in the United States

    2012

  23. Accelerating the Development of New Drugs and Diagnostics

    Accelerating the Development of New Drugs and Diagnostics

    2012

  24. Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis

    Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis

    2013

  25. Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis

    Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant Tuberculosis

    2013

  26. Sharing Clinical Research Data

    Sharing Clinical Research Data

    2013

  27. Envisioning a Transformed Clinical Trials Enterprise for 2030

    Envisioning a Transformed Clinical Trials Enterprise for 2030

    2022

  28. International Regulatory Harmonization Amid Globalization of Drug Development

    International Regulatory Harmonization Amid Globalization of Drug Development

    2013

  29. Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS

    Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS

    2014

  30. Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS

    Global Crisis of Drug-Resistant Tuberculosis and Leadership of China and the BRICS

    2014

  31. Large Simple Trials and Knowledge Generation in a Learning Health System

    Large Simple Trials and Knowledge Generation in a Learning Health System

    2013

  32. Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products

    Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products

    2014

  33. Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders

    Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders

    2015

  34. Rapid Medical Countermeasure Response to Infectious Diseases

    Rapid Medical Countermeasure Response to Infectious Diseases

    2016

  35. Advancing the Discipline of Regulatory Science for Medical Product Development

    Advancing the Discipline of Regulatory Science for Medical Product Development

    2016

  36. Advancing the Discipline of Regulatory Science for Medical Product Development

    Advancing the Discipline of Regulatory Science for Medical Product Development

    2016

  37. Deriving Drug Discovery Value from Large-Scale Genetic Bioresources

    Deriving Drug Discovery Value from Large-Scale Genetic Bioresources

    2016

  38. Real-World Evidence Generation and Evaluation of Therapeutics

    Real-World Evidence Generation and Evaluation of Therapeutics

    2017

  39. Enabling Precision Medicine

    Enabling Precision Medicine

    2017

  40. Examining the Impact of Real-World Evidence on Medical Product Development

    Examining the Impact of Real-World Evidence on Medical Product Development

    2019

  41. Virtual Clinical Trials

    Virtual Clinical Trials

    2019

  42. Enhancing Scientific Reproducibility in Biomedical Research Through Transparent Reporting

    Enhancing Scientific Reproducibility in Biomedical Research Through Transparent Reporting

    2020

  43. Reflections on Sharing Clinical Trial Data

    Reflections on Sharing Clinical Trial Data

    2020

  44. Role of Digital Health Technologies in Drug Development

    Role of Digital Health Technologies in Drug Development

    2020

  45. Drug Research and Development for Adults Across the Older Age Span

    Drug Research and Development for Adults Across the Older Age Span

    2021

  46. Inclusion of Pregnant and Lactating Persons in Clinical Trials

    Inclusion of Pregnant and Lactating Persons in Clinical Trials

    2023

  47. Accelerating the Development and Uptake of Rapid Diagnostics to Address Antibiotic Resistance

    Accelerating the Development and Uptake of Rapid Diagnostics to Address Antibiotic Resistance

    2023

  48. Defining and Evaluating In-Home Drug Disposal Systems For Opioid Analgesics

    Defining and Evaluating In-Home Drug Disposal Systems For Opioid Analgesics

    2024

  49. Addressing Treatment Resistance in the Development of Cancer Immune Modulator Therapeutics

    Addressing Treatment Resistance in the Development of Cancer Immune Modulator Therapeutics

    2024

  50. Preparing the Future Workforce in Drug Research and Development

    Preparing the Future Workforce in Drug Research and Development

    2024

  51. Optimizing Public–Private Partnerships for Clinical Cancer Research

    Optimizing Public–Private Partnerships for Clinical Cancer Research

    2024

  52. Optimizing Public-Private Partnerships for Clinical Cancer Research

    Optimizing Public-Private Partnerships for Clinical Cancer Research

    2024

  53. Adult Attention-Deficit/Hyperactivity Disorder

    Adult Attention-Deficit/Hyperactivity Disorder

    2024

  54. Toward a Framework to Improve Diversity and Inclusion in Clinical Trials

    Toward a Framework to Improve Diversity and Inclusion in Clinical Trials

    2025

  55. Challenges for the FDA

    Challenges for the FDA

    2007

  56. Emerging Safety Science

    Emerging Safety Science

    2008

  57. Public Health Emergency Medical Countermeasures Enterprise

    Public Health Emergency Medical Countermeasures Enterprise

    2010

  58. Building a National Framework for the Establishment of Regulatory Science for Drug Development

    Building a National Framework for the Establishment of Regulatory Science for Drug Development

    2011

  59. Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders

    Financial Incentives to Encourage Development of Therapies That Address Unmet Medical Needs for Nervous System Disorders

    2015

  60. Innovations in Pharmacy Training and Sustainable Practice to Advance Patient Care

    Innovations in Pharmacy Training and Sustainable Practice to Advance Patient Care

    2025